Based on this latest research, Dr. Hedrick estimates that increasing the levels of ABCG1 in diabetic patients may benefit from one of two ways – by helping to reduce the accumulation of plaque in blood pressure and improve insulin production.Matthias von Herrath, MD, director of the La Jolla Institute for Type 1 Diabetes Research Centre, accepted and welcomed the finding ABCG1 as an important step in understanding the cellular mechanisms of insulin secretion. The discovery of Dr. Hedrick provides important information on possible ways to increase the production of insulin, which is essential to control both types of diabetes, said Dr. We are pleased that she has recently joined our Institute and contribute to the efforts of our Centre against this terrible disease.
Dr. Hedrick, who researches before the strong correlation between diabetes and heart disease, began to study the protein ABCG1 several years ago while watching the build-up of coronary plaque and cholesterol in people with diabetes. The main function of ABCG1 is known to remove excess cholesterol from the body. But with this study, we found a new function for ABCG1 protein. Everyone thinks of cholesterol is bad. But in reality, scientists have long known that it is an essential component of all cell membranes.
Work in mouse models, the team found that ABCG1 protein is essential for pancreatic beta cells to produce sufficient quantities of insulin. Insulin is necessary for the body to convert glucose from food into energy. Problems with the production of insulin at the base of both type 1 and type 2 diabetes. Our studies in mice, it is believed that some patients with diabetes may have reduced the expression of ABCG1, which compromises their insulin, said Dr.
A surprising finding of our study is that the ABCG1 action in beta cells is actually intracellular, said Dr. Sturek at the University of Virginia. We found that most of ABCG1 is actually located inside the cell and the beta is really important to ensure intracellular cholesterol to the membrane of insulin granules. Without the delivery of cholesterol by ABCG1 these membranes, the granules of insulin do not develop or function properly and, therefore, significantly less insulin release. This is particularly interesting because it suggests that we examine the roles for intracellular ABCG1 other cell types.
In previous studies, Dr. Hedrick and his team had also made the observation that people with type 2 diabetes have relatively low levels of ABCG1. We theorized that this has contributed to high rates of cardiovascular disease in type 2 diabetes after failure to successfully remove cholesterol from the arteries can lead to a buildup of arterial plaque, a key factor in heart disease.
Our study suggests that some current anti-diabetic drugs may also provide therapeutic benefits associated with the restoration of normal levels of ABCG1 protein in beta cells and improve insulin secretion in people with type 2 diabetes, said Dr. Hedrick . Our research highlights the need to investigate this possibility and to explore the potential development of new therapies that stimulate ABCG1 protein levels and secretion of insulin, he said.
Collaborating with Leslie Tung, a professor of biomedical engineering at Johns Hopkins School of Medicine, researchers found that after a few more days of growth, cells on the nanostructured surface began to conduct electric waves and a strong contraction in a specific direction, as the heart muscle is intact. ‘Perhaps the most surprising, these features of the fabric and structure of modified cardiac tissue can be controlled simply by changing the properties of nanoscale scaffold. This shows us that heart cells have a short’ nanosense ‘, ‘Levchenko said.